src kinase inhibitor Search Results


94
MedChemExpress src inhibitor 1
Src Inhibitor 1, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/src inhibitor 1/product/MedChemExpress
Average 94 stars, based on 1 article reviews
src inhibitor 1 - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

96
TargetMol src inhibitor 1
Src Inhibitor 1, supplied by TargetMol, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/src inhibitor 1/product/TargetMol
Average 96 stars, based on 1 article reviews
src inhibitor 1 - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

94
Santa Cruz Biotechnology src inhibitor pp2
Src Inhibitor Pp2, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/src inhibitor pp2/product/Santa Cruz Biotechnology
Average 94 stars, based on 1 article reviews
src inhibitor pp2 - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

93
Boster Bio rabbit anti npepps
Rabbit Anti Npepps, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti npepps/product/Boster Bio
Average 93 stars, based on 1 article reviews
rabbit anti npepps - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

90
Biomol GmbH src family kinase inhibitors pp1 and pp2
Src Family Kinase Inhibitors Pp1 And Pp2, supplied by Biomol GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/src family kinase inhibitors pp1 and pp2/product/Biomol GmbH
Average 90 stars, based on 1 article reviews
src family kinase inhibitors pp1 and pp2 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Biomol GmbH src tyrosine kinase substrate
Src Tyrosine Kinase Substrate, supplied by Biomol GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/src tyrosine kinase substrate/product/Biomol GmbH
Average 90 stars, based on 1 article reviews
src tyrosine kinase substrate - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Topivert Inc inhibitors of p38 map kinase (particularly α and γ isoforms) and src kinase
Inhibitors Of P38 Map Kinase (Particularly α And γ Isoforms) And Src Kinase, supplied by Topivert Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/inhibitors of p38 map kinase (particularly α and γ isoforms) and src kinase/product/Topivert Inc
Average 90 stars, based on 1 article reviews
inhibitors of p38 map kinase (particularly α and γ isoforms) and src kinase - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Cayman Chemical src kinase inhibitor pp1
Src Kinase Inhibitor Pp1, supplied by Cayman Chemical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/src kinase inhibitor pp1/product/Cayman Chemical
Average 90 stars, based on 1 article reviews
src kinase inhibitor pp1 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Novartis abl and src family kinase inhibitor dasatinib
Abl And Src Family Kinase Inhibitor Dasatinib, supplied by Novartis, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/abl and src family kinase inhibitor dasatinib/product/Novartis
Average 90 stars, based on 1 article reviews
abl and src family kinase inhibitor dasatinib - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Enzo Biochem src kinases inhibitor pp1
Src Kinases Inhibitor Pp1, supplied by Enzo Biochem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/src kinases inhibitor pp1/product/Enzo Biochem
Average 90 stars, based on 1 article reviews
src kinases inhibitor pp1 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
AG Scientific src kinase-specific inhibitor (pp1)
Src Kinase Specific Inhibitor (Pp1), supplied by AG Scientific, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/src kinase-specific inhibitor (pp1)/product/AG Scientific
Average 90 stars, based on 1 article reviews
src kinase-specific inhibitor (pp1) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Merck KGaA src family tyrosine kinase inhibitor pp2
CD93 triggers the pY774-Cbl-dependent signaling pathway in spreading ECs. ( a ) Cell lysates from early spreading HUVECs pretreated for 30 min with vehicle alone (DMSO) or 10 μM <t>PP2</t> were analyzed by Western blotting using antibodies against pY774-Cbl and pY418-Src to confirm PP2 activity. Equal loading was confirmed by using anti-Cbl and anti-Src antibodies. ( b ) Quantification of pY774-Cbl phosphorylation levels from independent experiments performed as in ( a ). Values, normalized to Cbl protein levels, represent the percentage of pY774-Cbl levels relative to vehicle-treated cells (DMSO). *** p < 0.001; paired t -test. ( c , d ) HUVECs were transduced with lentiviral particles expressing unrelated (sh-unr) or CD93 shRNA (sh-CD93). Cells were detached from the plate, resuspended in complete growth medium, plated on the substrate, and fixed at early phases of spreading. Cells were analyzed by immunofluorescence using phalloidin, anti-CD93 antibody, and antibodies against pY774-Cbl ( c ) and Crk ( d ). White dot colocalization (wdc) images are shown as indicated. In the wdc pictures, magnification of the squared areas is shown (2.5×). Scale bars, 20 μm. ( e , f ) Quantification of cellular pY774-Cbl ( e ) and Crk ( f ) in the spreading border area (5 μm from the cell edge) of HUVECs transduced and treated as in ( c ) ( n = 14 cells for sh-unr and n = 16 cells for sh-CD93) and ( d ) ( n = 15 cells for sh-unr and n = 14 cells for sh-CD93). Data are presented as scatter plots and the fluorescence intensity of the pY774-Cbl +ve and Crk +ve signals per area is reported as arbitrary units (AU). * p < 0.05; Student t -test ( e ). *** p < 0.001; Mann–Whitney test ( f ).
Src Family Tyrosine Kinase Inhibitor Pp2, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/src family tyrosine kinase inhibitor pp2/product/Merck KGaA
Average 90 stars, based on 1 article reviews
src family tyrosine kinase inhibitor pp2 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


CD93 triggers the pY774-Cbl-dependent signaling pathway in spreading ECs. ( a ) Cell lysates from early spreading HUVECs pretreated for 30 min with vehicle alone (DMSO) or 10 μM PP2 were analyzed by Western blotting using antibodies against pY774-Cbl and pY418-Src to confirm PP2 activity. Equal loading was confirmed by using anti-Cbl and anti-Src antibodies. ( b ) Quantification of pY774-Cbl phosphorylation levels from independent experiments performed as in ( a ). Values, normalized to Cbl protein levels, represent the percentage of pY774-Cbl levels relative to vehicle-treated cells (DMSO). *** p < 0.001; paired t -test. ( c , d ) HUVECs were transduced with lentiviral particles expressing unrelated (sh-unr) or CD93 shRNA (sh-CD93). Cells were detached from the plate, resuspended in complete growth medium, plated on the substrate, and fixed at early phases of spreading. Cells were analyzed by immunofluorescence using phalloidin, anti-CD93 antibody, and antibodies against pY774-Cbl ( c ) and Crk ( d ). White dot colocalization (wdc) images are shown as indicated. In the wdc pictures, magnification of the squared areas is shown (2.5×). Scale bars, 20 μm. ( e , f ) Quantification of cellular pY774-Cbl ( e ) and Crk ( f ) in the spreading border area (5 μm from the cell edge) of HUVECs transduced and treated as in ( c ) ( n = 14 cells for sh-unr and n = 16 cells for sh-CD93) and ( d ) ( n = 15 cells for sh-unr and n = 14 cells for sh-CD93). Data are presented as scatter plots and the fluorescence intensity of the pY774-Cbl +ve and Crk +ve signals per area is reported as arbitrary units (AU). * p < 0.05; Student t -test ( e ). *** p < 0.001; Mann–Whitney test ( f ).

Journal: International Journal of Molecular Sciences

Article Title: CD93 Signaling via Rho Proteins Drives Cytoskeletal Remodeling in Spreading Endothelial Cells

doi: 10.3390/ijms222212417

Figure Lengend Snippet: CD93 triggers the pY774-Cbl-dependent signaling pathway in spreading ECs. ( a ) Cell lysates from early spreading HUVECs pretreated for 30 min with vehicle alone (DMSO) or 10 μM PP2 were analyzed by Western blotting using antibodies against pY774-Cbl and pY418-Src to confirm PP2 activity. Equal loading was confirmed by using anti-Cbl and anti-Src antibodies. ( b ) Quantification of pY774-Cbl phosphorylation levels from independent experiments performed as in ( a ). Values, normalized to Cbl protein levels, represent the percentage of pY774-Cbl levels relative to vehicle-treated cells (DMSO). *** p < 0.001; paired t -test. ( c , d ) HUVECs were transduced with lentiviral particles expressing unrelated (sh-unr) or CD93 shRNA (sh-CD93). Cells were detached from the plate, resuspended in complete growth medium, plated on the substrate, and fixed at early phases of spreading. Cells were analyzed by immunofluorescence using phalloidin, anti-CD93 antibody, and antibodies against pY774-Cbl ( c ) and Crk ( d ). White dot colocalization (wdc) images are shown as indicated. In the wdc pictures, magnification of the squared areas is shown (2.5×). Scale bars, 20 μm. ( e , f ) Quantification of cellular pY774-Cbl ( e ) and Crk ( f ) in the spreading border area (5 μm from the cell edge) of HUVECs transduced and treated as in ( c ) ( n = 14 cells for sh-unr and n = 16 cells for sh-CD93) and ( d ) ( n = 15 cells for sh-unr and n = 14 cells for sh-CD93). Data are presented as scatter plots and the fluorescence intensity of the pY774-Cbl +ve and Crk +ve signals per area is reported as arbitrary units (AU). * p < 0.05; Student t -test ( e ). *** p < 0.001; Mann–Whitney test ( f ).

Article Snippet: The Src family tyrosine kinase inhibitor PP2 was purchased from Merck KGaA.

Techniques: Western Blot, Activity Assay, Phospho-proteomics, Transduction, Expressing, shRNA, Immunofluorescence, Fluorescence, MANN-WHITNEY